# \[Go Awf\] Ozempic: Miracle Drug or Just Hype? What You Need to Know About GLP-1s

An episode of [Awf The Record](https://invisiblenetwork.ai/podcast/1758650789), 16 Dec 2025, 6:25.

Audio: https://www.buzzsprout.com/2372866/episodes/18360194-go-awf-ozempic-miracle-drug-or-just-hype-what-you-need-to-know-about-glp-1s.mp3

Send us Fan Mail Is Ozempic really the weight loss solution we’ve been waiting for or is it more complicated than that? In this must-listen segment, Dr. Darien Sutton breaks down the truth behind Ozempic and GLP-1 medications; what they actually do, who they’re for, and why obesity is much more than a matter of willpower. From Serena Williams headlines to the science of chronic weight gain, this convo dives into the real root causes of obesity, metabolic health, and the limits of “quick fix” thinking. If you’re curious, confused, or just tired of the hot takes, this one clears it all up. GUEST RESOURCES Dr. Darien Sutton IG | @doctor.darien/ RESOURCES: Keep in touch with Awf The Record: Youtube: @AwfTheRecord Instagram: @awftherecordpodcast TikTok: @AwfTheRecord Mona Kosar Abdi IG | @monakabdi Jeannette Reyes IG | @msnewslady Keep in touch with Awf The Record: Watch on Youtube: @AwfTheRecord Follow us on Instagram: @awftherecordpodcast Follow us on TikTok: @AwfTheRecord Visit our website: www.AwfTheRecord.com Follow Mona on TikTok and IG Follow Jeannette on TikTok and IG

## Transcript

[0:00] SPEAKER_01: This is off the record, not for real.
[0:02] SPEAKER_01: This is off the record.
[0:04] SPEAKER_01: It's so timely because it's happening at a time where there's so much misinformation, disinformation that can be harmful, particularly in the medical field.
[0:12] SPEAKER_01: Absolutely.
[0:12] SPEAKER_01: Ozempic has been the latest kind of headliner.
[0:15] SPEAKER_01: It's funny, because Mona and I were actually thinking about talking about this last year.
[0:18] SPEAKER_02: Yeah.
[0:18] SPEAKER_01: And when it didn't work out, we thought certain, you know, surely things are gonna die down.
[0:22] SPEAKER_01: And the year later, right, Serena's really pushed it back into the headlines when it comes to Ozempic and GLP1 medication.
[0:29] SPEAKER_02: I actually was very surprised about the reception because y'all know me, I run straight to the comments.
[0:36] SPEAKER_02: And when I opened up the comments, I was thinking, and maybe these are my own biases, but I was like, oh, Serena, someone who is an exceptional athlete, right, is using this, I felt like people would think, oh, as a celebrity, you're pushing it.
[0:50] SPEAKER_02: Um, maybe this is the easy way out.
[0:52] SPEAKER_02: Or, and mind you, I've done stories on Ossempic.
[0:55] SPEAKER_02: So I understand the necessity or GLP ones.
[0:58] SPEAKER_02: But when I opened the comments, I was very surprised that people were like, thank you.
[1:02] SPEAKER_02: Thank you for number one, being transparent about it.
[1:05] SPEAKER_02: And number two, if someone like you who works out a million times a day and is a world-class athlete still is struggling to lose weight, then hello, the rest of us are struggling, right?
[1:17] SPEAKER_02: So were you surprised about the reception?
[1:19] SPEAKER_00: No, because I think that as a physician, I interact with people and I hear their personal real stories, and it helps me to give get a better understanding of the reality of what obesity looks like, what gaining weight looks like, and how for many people it is not a simple thing of choice.
[1:34] SPEAKER_00: I think that historically we've always said, well, it's obviously something that you are doing.
[1:38] SPEAKER_00: You're obviously not working out enough, you're obviously eating too many calories, and you're gaining weight.
[1:42] SPEAKER_00: And while that is basic math that leads to gaining weight, uh weight gain and obesity are so much more complex than that.
[1:48] SPEAKER_00: They can be secondary to not just what we eat, but also the environment around us, the access that we have.
[1:54] SPEAKER_00: Some people simply don't have safe spaces even to work out, and I think that has to be acknowledged to the food that we have access to in the grocery store.
[2:00] SPEAKER_00: You know, when we see rates of poverty rise, we see rates of obesity rise.
[2:04] SPEAKER_00: And that's not because of gluttony, that's because people don't have access to nutritious sources of food.
[2:09] SPEAKER_00: And so that's one component of it.
[2:11] SPEAKER_00: But then there's another biological reasoning behind that.
[2:13] SPEAKER_00: There are some that have conditions like polycystic ovarian syndrome, a very common hormonal condition that exists among women, where a side effect can be gaining weight.
[2:21] SPEAKER_00: And there are some patients who are taking medications to treat other syndromes where a side effect of those medications is weight gain.
[2:27] SPEAKER_00: And so I think now we're starting to understand that obesity in and of itself is a complex chronic diagnosis that is often relapsing.
[2:34] SPEAKER_00: And if we continue to try to just simply say it's a matter of choice, we're not going to treat it at its root cause.
[2:39] SPEAKER_00: So I think as being a good physician, is trying to make sure I take a step back and take myself out of it, which is what I encourage everyone to do, because the minute you hear people talk about weight management, you'll hear people say, Well, this is what I did.
[2:51] SPEAKER_00: And it's like, okay, thank you.
[2:52] SPEAKER_00: Uh, but that's not what someone else can do or might have access to.
[2:56] SPEAKER_00: And instead, looking at it from a thousand-foot perspective and realizing, oh, wow, this is so much more complex than I ever initially thought.
[3:03] SPEAKER_01: It's interesting because when you hear that, one might say, Well, then GLP1s are the magic drug.
[3:10] SPEAKER_01: This is the thing that we have been waiting for for decades.
[3:14] SPEAKER_01: Is it as simple as that?
[3:16] SPEAKER_01: I know there have been some concerns about, hey guys, decades from now, we might realize the cons far outweigh the pros.
[3:22] SPEAKER_00: You know, I think looking at any intervention as the simple fix of a complex problem such as obesity, I think would be very naive.
[3:31] SPEAKER_00: And so for me as uh a physician and a scientist, looking back and understanding, well, what is the root cause to the rising rate of obesity within the United States?
[3:40] SPEAKER_00: Now, that in and of itself is a complex discussion that we could have a whole separate TED Talk podcast about.
[3:45] SPEAKER_00: Because, in terms of access, in terms of the uh social determinants that lead to the outcomes of obesity.
[3:51] SPEAKER_00: But in terms of understanding the metabolic syndrome, I don't look at it as a simple um silver bullet.
[3:57] SPEAKER_00: I do look at this class of medications, however, as a puzzle piece, a missing puzzle piece to the complex picture that is that metabolic syndrome.
[4:05] SPEAKER_00: And now, like adventurers into the deep sea or a space, we're we're actually realizing that there are parts of the body we just didn't understand how they worked.
[4:11] SPEAKER_00: And that's what the purpose of research and technology and studies are, to understand these parts.
[4:16] SPEAKER_00: And so I do believe, although it's not a silver bullet, I do believe it is a big missing puzzle piece to the clue of obesity and the metabolic syndrome that surrounds that, that many scientists have been trying to understand for decades.
[4:28] SPEAKER_02: Is this first like a lifelong drug?
[4:31] SPEAKER_02: If you're on it in order to manage your weight, if you are someone who has, you know, metabolic issues and and can't seem to lose weight on their own, is this something that you're gonna be on for the rest of your life?
[4:41] SPEAKER_00: To understand obesity, number one, it's chronic often and it is often relapsing.
[4:45] SPEAKER_00: And I think sometimes people look at these medications as a simple fix, like I just want to fit into this outfit, or I just want to make sure that I can lose this weight so I can keep it off.
[4:54] SPEAKER_00: And while that is possible, because obviously with significant interventions outside of this medication, because it's meant to be used in conjunction with other lifestyle changes in terms of nutrition, movement, and continued monitoring with your physician, we do see that when patients come off of these medications, when we look at withdrawal studies, when we take patients off those or when scientists take patients off those medications and see what happens, weight gain happens.
[5:18] SPEAKER_00: And so in certain studies for semaglitide or semaglutide, the active ingredient in Ozempic, when they take the medication off or patients off the medication, they find that they gain up to two-thirds of their weight that they had lost.
[5:29] SPEAKER_00: And the same thing that they see with terzepatide, which is a similar GLP but in the same picture, and it's the active ingredient in Zep bound, patients gain weight.
[5:37] SPEAKER_00: So that tells us that number one, obesity, yes, it is relapsing and it is chronic.
[5:42] SPEAKER_00: And these medications seem to only work while they're being used.
[5:45] SPEAKER_00: And so if you are looking for sustained continued weight loss, it is likely that you're going to need some type of intervention.
[5:53] SPEAKER_00: Is that going to be a GLP for the rest of your life?
[5:55] SPEAKER_00: Possibly.
[5:55] SPEAKER_00: Is that going to be a GLP and then maybe new medications that come out in the future?
[5:59] SPEAKER_00: Possibly.
[6:00] SPEAKER_00: Or is that going to mean that you change, uh you're able to uh get yourself back into the gym, you're able to be more mobile, you're able to have more of uh self confidence, and you're able to enact uh some of those interventions in your life that you weren't able to do before you lost that weight.
[6:14] SPEAKER_00: And now you're using those interventions as a way to keep that weight off.
[6:17] SPEAKER_00: That is also possible.
[6:18] SPEAKER_00: So all of those outcomes are possible.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.
